EVOLUTION AT MERCK - INVENTING FOR LIFE

KEYTRUDA: STILL IN EARLY INNINGS OF DEVELOPMENT >100 Trials in adjuvant / neoadjuvant and earlier lines >1,000 Ongoing clinical >600 Combination trials trials O Continuing to build a wall of data >75 Registrational trials underway MERCK # Dr. Roy Baynes | INVENTING FOR LIFE 51

View entire presentation